This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
₹0.008558
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) Fails to deliver data
Key failure to deliver metrics for Genocea Biosciences :
- Last SEC data release: 2023-07-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Genocea Biosciences (GNCA) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Genocea Biosciences (GNCA) - since 2019
Volume in USD (price x number of shares), data since 2019Genocea Biosciences (GNCA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | ₹0.23 M | -97.52% |
| 2021 | ₹9.66 M | 27.23% |
| 2020 | ₹7.59 M | 215.89% |
| 2019 | ₹2.4 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | N/A | ₹0.7 M | 🇺🇸 USA |
 | ₹7.68 M | ₹0.12 B | 🇺🇸 USA |
 | ₹0.10 B | ₹0.17 B | 🇺🇸 USA |
 | ₹0.83 M | ₹6.18 M | 🇺🇸 USA |
 | ₹32.79 M | ₹0.34 B | 🇺🇸 USA |